Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies.
Saved in:
| Title: | Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies. |
|---|---|
| Authors: | Angotzi F; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Petrella M; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Berno T; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Binotto G; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Bonetto G; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Branca A; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Carraro M; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Cavaretta CA; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Cellini A; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., D'Amore F; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Forlani L; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Gianesello I; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Gurrieri C; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Imbergamo S; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Lessi F; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Maroccia A; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Mazzetto F; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Pavan L; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Pezone S; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Piazza F; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Pravato S; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Ruocco V; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Scapinello G; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Vianello F; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Zambello R; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Zatta I; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Zoletto S; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Padoan A; Department of Integrated Diagnostic Medicine, Laboratory Medicine Unit, University of Padova, Padova, Italy., Trentin L; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Visentin A; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy. |
| Source: | Frontiers in oncology [Front Oncol] 2023 Jun 22; Vol. 13, pp. 1212752. Date of Electronic Publication: 2023 Jun 22 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
